lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Severity and Case Fatality Rates of COVID-19: A Systematic Review, Meta-Analysis and an Exploratory Meta-Regression of Risk Factors

38 Pages Posted: 15 Apr 2020

See all articles by Chanaka Kahathuduwa

Chanaka Kahathuduwa

Texas Tech University - Department of Laboratory Science and Primary Care

Chathurika Dhanasekara

Texas Tech University - Department of Surgery

Shao-Hua Chin

Protech Pharmaservices Corporation - Department of Medical Science

More...

Abstract

Background: Estimating the prevalence of severe or critical illness and case fatality of COVID-19 outbreak in December, 2019 remains a challenge due to biases associated with surveillance, data synthesis and reporting. We aimed to address this limitation in a systematic review and meta-analysis and to examine the clinical, biochemical and radiological risk factors in a meta-regression.

Methods: PRISMA guidelines were followed. PubMed, Scopus and Web of Science were searched using pre-specified keywords on March 07, 2020. Peer-reviewed empirical studies examining prevalence rates of severe illness, critical illness and mortality among COVID-19 patients were examined. Numerators and denominators to compute the prevalence rates and risk factors were extracted. Random-effects meta-analyses were performed. Results were corrected for publication bias. Meta-regression analyses examined the moderator effects of potential risk factors.

Findings: The meta-analysis included 29 studies representing 2,090 individuals. Pooled rates of severe illness, critical illness and case fatality among COVID-19 patients were 15%, 5% and 0.8% respectively. Adjusting for potential underreporting and publication bias, increased these estimates to 26%, 16% and 7.4% respectively. Increasing age and elevated LDH consistently predicted severe / critical disease and case fatality. Hypertension; fever and dyspnea at presentation; and elevated CRP predicted increased severity.

Interpretation: Risk factors that emerged in our analyses predicting severity and case fatality should inform clinicians to define endophenotypes possessing a greater risk. Estimated case fatality rate of 7.4% after correcting for publication bias underscores the importance of strict adherence to preventive measures, case detection, surveillance and reporting.

Funding Statement: None

Declaration of Interests: The authors declare no competing interests.

Keywords: COVID-19; Mortality; Case fatality; Systematic review; Meta-analysis; Metaregression

Suggested Citation

Kahathuduwa, Chanaka and Dhanasekara, Chathurika and Chin, Shao-Hua, Severity and Case Fatality Rates of COVID-19: A Systematic Review, Meta-Analysis and an Exploratory Meta-Regression of Risk Factors (3/27/2020). Available at SSRN: https://ssrn.com/abstract=3564410 or http://dx.doi.org/10.2139/ssrn.3564410

Chanaka Kahathuduwa (Contact Author)

Texas Tech University - Department of Laboratory Science and Primary Care ( email )

United States

Chathurika Dhanasekara

Texas Tech University - Department of Surgery

United States

Shao-Hua Chin

Protech Pharmaservices Corporation - Department of Medical Science

Taiwan

Click here to go to TheLancet.com

Paper statistics

Downloads
286
Abstract Views
2,354
PlumX Metrics